Predicting mRNA degradation to improve vaccine stability

Messenger Ribonucleic Acid (mRNA) as a therapeutic approach is gaining momentum due to its ability to be rapidly manufactured and its promising outcomes. mRNA-based vaccines, for instance, played a crucial role in the fight against COVID-19 in many parts of the world.

Leave A Comment

Your email address will not be published. Required fields are marked *